Antiendothelial cell antibodies (AECAs) are commonly detectable in diseases associated with vascular injury, including systemic lupus erythematosus (SLE), systemic sclerosis, Takayasu arteritis, Wegener granulomatosis, Behç et syndrome, and transplant arteriosclerosis. Here, we explore the hypothesis that these antibodies might augment polymorphonuclear leukocyte (PMN) adhesion to endothelium in inflammation. Initially, we established that a mouse IgG mAb bound to endothelial cells (ECs) significantly increased PMN adhesion to cytokine-stimulated endothelium in an Fc␥RIIa-dependent manner. Neutralizing antibodies, and adenoviral transduction of resting ECs, demonstrated that the combination of Eselectin, CXCR1/2, and  2 integrins is both necessary and sufficient for this process. We observed an identical mechanism using AECA IgG isolated directly from patients with SLE. Assembled immune complexes also enhanced PMN adhesion to endothelium, but, in contrast to adhesion because of AECAs, this process did not require CXCR1/2, was not inhibited by pertussis toxin, and was Fc␥RIIIb rather than Fc␥RIIa dependent.
IntroductionThe recruitment of circulating polymorphonuclear leukocytes (PMNs) to sites of inflammation is mediated by a series of adhesion and activation steps, known as the "adhesion cascade." 1 Thus, selectins are largely responsible for initial tethering of flowing PMNs to endothelium and also mediate subsequent PMN rolling on the endothelial surface. Activation of rolling PMNs leads to leukocyte arrest via modulation of the affinity and avidity of  2 integrins, with LFA-1 (CD11a/CD18) acting primarily to slow rolling and to promote arrest, and Mac-1 (CD11b/CD18) acting to stabilize adhesion. [2][3][4][5] The capacity of endothelial cells (ECs) to support these interactions with PMNs is stimulated by cytokines such as TNF␣ and IL-1, which induce expression of a large number of adhesion molecules, chemottractant, and other proinflammatory genes, including E-selectin, chemokines (eg, IL-8), and ICAM-1. 6,7 Antibodies that react with the surface of vascular endothelial cells (antiendothelial cell antibodies, AECAs) are found in a variety of diseases associated with vascular injury, including systemic lupus erythematosus (SLE), systemic sclerosis, Takayasu arteritis, Wegener granulomatosis, Behçets syndrome, and transplant arteriosclerosis, 8,9 A number of mechanisms have been proposed whereby IgG binding to ECs may exert pathogenic effects, including the induction of EC inflammatory activation and thrombogenicity, the stimulation of leukocyte free-radical production and cellular cytotoxicity, and the induction of EC apoptosis. [10][11][12][13][14] Interactions between circulating human PMNs and immune complexes are mediated via 2 low-affinity Fc␥ receptors, Fc␥RIIa (CD32a) and Fc␥RIIIb (CD16b), which are both thought to form homodimers and have distinct membrane-anchoring and -signaling capacities. [15][16][17][18][19] The cytoplasmic domain of Fc␥RIIa has a specialized immunoreceptor tyrosine-based activ...